Refine your search
-
Authors
-
Item types
-
Topics
- *Absorbable Implants
- *Advisory Committees
- *Cardiovascular Agents/ad [Administration & Dosage]
- *Coated Materials, Biocompatible
- *Coronary Artery Disease/th [Therapy]
- *Device Approval
- *Drug-Eluting Stents
- *Everolimus/ad [Administration & Dosage]
- *Percutaneous Coronary Intervention/is [Instrumentation]
- *Sirolimus/ad [Administration & Dosage]
- *United States Food and Drug Administration
- Aged
- Cardiovascular Agents/ae [Adverse Effects]
- Coronary Artery Disease/dg [Diagnostic Imaging] [x]
- Everolimus/ae [Adverse Effects]
- Humans
- Percutaneous Coronary Intervention/ae [Adverse Effects]
- Prosthesis Design
- Time Factors
- Treatment Outcome
- Show more
- Show less
-
Collections
-
Languages